K. Peter Etzkorn
About
In The Last Decade
K. Peter Etzkorn
54 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 146
- Surgery 378
- Sociology and Political Science 355
- Hepatology 331
- Music 314
- Epidemiology 313
Countries citing papers authored by K. Peter Etzkorn
This map shows the geographic impact of K. Peter Etzkorn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Peter Etzkorn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Peter Etzkorn more than expected).
Fields of papers citing papers by K. Peter Etzkorn
This network shows the impact of papers produced by K. Peter Etzkorn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Peter Etzkorn. The network helps show where K. Peter Etzkorn may publish in the future.
Co-authorship network of co-authors of K. Peter Etzkorn
This figure shows the co-authorship network connecting the top 25 collaborators of K. Peter Etzkorn. A scholar is included among the top collaborators of K. Peter Etzkorn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Peter Etzkorn. K. Peter Etzkorn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 196 | |
| 2 | 60 | |
| 3 | Simeprevir plus sofosbuvir (12 and 8 weeks) in hepatitis C virus genotype 1-infected patients without cirrhosis: OPTIMIST-1, a phase 3, randomized study | 5 |
| 4 | Sofosbuvir With Velpatasvir in Treatment-Naive Noncirrhotic Patients With Genotype 1 to 6 Hepatitis C Virus Infection | 4 |
| 5 | 41 | |
| 6 | 33 | |
| 7 | 4 | |
| 8 | 76 | |
| 9 | 11 | |
| 10 | 7 | |
| 11 | 58 | |
| 12 | 25 | |
| 13 | 9 | |
| 14 | 29 | |
| 15 | On the Sociology of Musical Practice and Social Groups. | 4 |
| 16 | 31 | |
| 17 | 11 | |
| 18 | The Future of Work and Leisure. breakdown → | 156 |
| 19 | 17 | |
| 20 | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.